Investment
Features
FeesSafety
Academy
More
Pluang+

Compare IQVIA Holdings Inc. Common Stock (IQV) vs Kyndryl Holdings Inc (KD) Price & Performance

IQVIA Holdings Inc. Common StockTrade
Kyndryl Holdings IncTrade

Price performance (Past 24H)

Key statistics

IQVIA Holdings Inc. Common Stock vs Kyndryl Holdings Inc — how do they compare? IQVIA Holdings Inc. Common Stock trades at $258.85 (market cap $42.61B), while Kyndryl Holdings Inc trades at $11.86 (market cap $2.59B). The key difference: IQVIA Holdings Inc. Common Stock is far larger — about 16.5× Kyndryl Holdings Inc's market cap, and IQVIA Holdings Inc. Common Stock is trading nearer its 52-week high, Kyndryl Holdings Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold IQVIA Holdings Inc. Common Stock for 0 Days and Kyndryl Holdings Inc for 36 Days on average.

IQVKD
Market Cap
$42.61B$2.59B
Volume
988,3985,354,348
Sector
HealthTechnology
52-Week High
$275.02$29.76
52-Week Low
$156.66$10.59
Typical Hold Time
0 Days36 Days
Enterprise Value
$56.77B$5.41B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

IQVIA Holdings Inc. Common Stock

No Aura AI signal available yet.

Kyndryl Holdings Inc

Kyndryl Holdings (KD) trades at $11.45, down 0.26% on the day, with technical indicators showing bearish momentum. The company reported mixed quarterly results, missing Q4 2025 and Q1 2026 EPS estimates but beating in Q2 2026. Recent financials show improved profitability with 2025 net income of $252 million, though revenue has declined from $18.3B in 2022 to $15.1B in 2025. Analyst sentiment is cautious with a consensus 'Hold' rating and $14.67 price target, while institutional activity includes recent purchases by Virginia Retirement Systems.

KD presents a turnaround story with improving profitability but faces revenue headwinds and competitive pressures. The stock trades at reasonable valuation multiples (P/E 30.95, P/S 0.18) with positive cash flow generation. Key risks include ongoing revenue declines and high debt levels, while opportunities exist in AI initiatives and government contracts. The current technical weakness may present entry points for patient investors betting on management's execution.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IQV
100% Buy0% Sell
Avg holding period · 0 Days
KD
100% Buy0% Sell
Avg holding period · 36 Days

Top news

Latest headlines on both assets

About IQVIA Holdings Inc. Common Stock

IQVIA provides clinical research, healthcare data, technology, and consulting services to life sciences companies. Its work supports drug development and commercialization.

Read more on IQV →

About Kyndryl Holdings Inc

Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.

Read more on KD →